MHRA warns students against self-prescribing The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a strong warning to students about the risks of self-prescribing and self-medicating with medicines bought online.…
MHRA expresses concerns over drugs sold online The Medicines Healthcare products and Regulatory Agency has met with the National Pharmacy Association to discuss concerns that community pharmacies are breaching legislation covering the online sale and supply of medicines in the UK.…
Alectinib reduces CNS progression in NSCLC Data from two clinical trials have shown that second-generation ALK inhibitor alectinib (Alecensa, Roche) reduces central nervous system progression in ALK-positive non-small cell lung carcinoma.…
MHRA issues drug alert after drugs mislabelled Pharmacists have been warned to be aware of possible wrong labelling on a number of batches of drugs including medicines to treat epilepsy, anxiety and depression.…
Dovonex psoriasis ointment now available without prescription Dovonex psoriasis ointment (50mg/g) will now be available through pharmacies without a prescription following approval by the Medicines and Healthcare products Regulatory Agency.…
MHRA publishes guide to new EU medical device laws The Medicines and Healthcare products Regulatory Agency has published an introductory guide for manufacturers to make sure their medical devices meet new European Union legislation.…
Insulin pens recalled Pharmacists have been told to ensure they do not dispense from 87 batches of insulin pens that could leave patients at risk of hyperglycaemia.…
MHRA seizes ‘unreliable’ HIV self-testing kits from UK suppliers The Medicines and Healthcare products Regulatory Agency (MHRA) has seized 114 “potentially unreliable” HIV home testing kits from two UK suppliers.…
MHRA advises health professionals on supply of clobazam for epilepsy An epilepsy charity has updated its advice for health professionals on the supply of clobazam for people with epilepsy.…
Michael Rawlins reappointed MHRA chair The Medicines and Healthcare products Regulatory Agency has announced that Michael Rawlins has been reappointed as its chair and will continue in the role for a further three years.…